Shmuel Benenson - Infectious Diseases

Author Information

Shmuel Benenson is affiliated with the Department of Clinical Microbiology and Infectious Diseases at the Hadassah-Hebrew University Medical Center, located in the Ein Kerem campus, Jerusalem, Israel. His professional focus lies within the field of infectious diseases, with a significant emphasis on understanding and combating various infectious agents, including SARS-CoV-2.

Research Contributions

Shmuel Benenson has made significant contributions to the field of infectious diseases, particularly in the context of COVID-19. His research extensively covers the effectiveness of COVID-19 vaccinations, including the BNT162b2 mRNA vaccine, as well as the epidemiology of SARS-CoV-2 infections among healthcare workers and specific patient populations. His studies also explore the validity of diagnostic methods for infections and the clinical manifestations of COVID-19 in different demographic groups, including children and neonates.

Aliases

The author is known by several aliases, including S Benenson, S. Benenson, and Shmuel Benenson.

Publication and Citation Metrics

Metric	Value
Total Papers	94
Total Citations	1732
H-index	27

Publications:

Effectiveness of the BNT162b vaccine fourth dose in reducing SARS-CoV-2 infection among healthcare workers in Israel, a multi-center cohort study

DOI: 10.1101/2022.04.11.22273327

Year: 2022

The validity of positive coagulase-negative Staphylococcus cultures for the diagnosis of sepsis in the neonatal unit.

DOI: 10.1055/a-1817-5698

Year: 2022

Sources of Primary Bloodstream Infections in Internal Medicine Patients – a Cohort Study

DOI: 10.21203/rs.3.rs-1215597/v1

Year: 2022

The effect of a third BNT162b2 vaccine on breakthrough infections in health care workers: a cohort analysis

DOI: 10.1016/j.cmi.2022.01.019

Year: 2022

Association Between Exposure Characteristics and the Risk for COVID-19 Infection Among Health Care Workers With and Without BNT162b2 Vaccination

DOI: 10.1001/jamanetworkopen.2021.25394

Year: 2021

Seizures as the main presenting manifestation of acute SARS-CoV-2 infection in children

DOI: 10.1016/j.seizure.2021.08.017

Year: 2021

High attack rate of COVID-19 in an organized tour group of vaccinated travellers to Iceland

DOI: 10.1093/jtm/taab157

Year: 2021

Rapid antigen detection testing for universal screening for severe acute respiratory syndrome coronavirus 2 in women admitted for delivery

DOI: 10.1016/j.ajog.2021.01.002

Year: 2021

Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination

DOI: 10.3389/fmed.2021.689994

Year: 2021

BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers

DOI: 10.1056/NEJMc2101951

Year: 2021

How is Bovine Tuberculosis Transmitted?

What is the CDCâs Role in Vaccine Development?

What are the Complications of Untreated Chlamydia?

What Are the Limitations of Blood Tests?

What is RT-PCR?

How is Avian Influenza Transmitted?

What Future Directions is the NIH Taking in Infectious Disease Research?

When Should Antipyretics be Used?

How often should you wash your hands?

What is Artemisinin-based Combination Therapy (ACT)?

Partnered Content Networks

Relevant Topics